Digital Health Startups

YPrime provides a clinical trial technology platform with patient engagement features (eConsent and eCOA) designed to accelerate trial timelines, improve data quality, and enhance participant experience for pharmaceutical companies, biotechs, and contract research organizations.

3 investors

YourCoach.Health operates a practice management platform and embeddable technology that lets health and wellness coaches manage their practices and connects organizations with validated, credentialed coaches. It serves industry partners looking to add or scale coaching operations as well as independent health coaches seeking a HIPAA-compliant platform and client opportunities.

3 investors

A Chinese healthcare technology company that operates an integrated ecosystem for patient care, including online consultation services, hospital management platforms, pharmaceutical services, and insurance solutions. The company serves patients, hospitals, doctors, and pharmacies through its interconnected digital health offerings.

3 investors

Zarminali Pediatrics operates pediatric clinics designed with evidence-based principles to reduce patient stress and improve family experience alongside medical care delivery.

3 investors

Zoundream applies artificial intelligence and sound recognition to analyze and translate newborns' cries in real time, identifying needs such as hunger or sleepiness. It also aims to support the identification and diagnosis of potential newborn pathologies and development disorders for parents and families.

3 investors

Zuri Fertility offers a fertility program serving individuals, employers, and clinics/providers, currently launching a pilot cohort. It operates in the fertility and reproductive healthcare space.

3 investors

Zymego provides appointment management software for healthcare clinics that enables patients to self-book, reschedule, and cancel appointments autonomously, reducing no-shows and wait times. The platform is designed to eliminate wasted appointment slots and free up administrative staff time in healthcare settings.

3 investors

MediAge builds digital healthcare data solutions that assess and manage users' health, including biological age analysis, comprehensive health risk evaluation, personalized nutrition analysis, and mobile health checkup management. It also operates national health screening management platforms and a health big data platform (DAMA) built with MediAge and Yonsei University Health System biobank data, based in South Korea.

3 investors

Exosystems develops AI-based digital biomarkers for the assessment, monitoring, and treatment of neuromuscular and musculoskeletal disorders, supporting diagnosis, severity assessment, and disease progression tracking for conditions such as stroke, Parkinson's, ALS, SMA, sarcopenia, and myasthenia gravis. Its technology aims to provide faster, non-invasive, and reproducible quantitative neuromuscular evaluations for clinical and healthcare settings.

3 investors

Healcerion develops portable, wire-free handheld ultrasound diagnostic devices under the SONON brand, intended to bring point-of-care imaging directly to patients. The company operates in the medical imaging and healthcare device industry.

3 investors

Alpha Fusion is a Japanese biotechnology company developing targeted alpha therapy drugs based on Astatine-211 (211At) to treat cancer with reduced side effects to healthy tissue.

3 investors

Allm uses information and communication technology to address healthcare disparities and mismatches, aiming to provide equitable medical and welfare services to all people. The company develops digital solutions and approaches to transform healthcare and welfare delivery.

3 investors

Shukun Technology, founded in 2017, develops medical AI products including its "Digital Human Body" platform, a multimodal medical large model called "Shukun Kun," and hundreds of "AI doctor" agents covering full-modality medical imaging. It provides AI-based diagnostic and healthcare services to hospitals, communities, cities, and individuals, and supports insurance, drug development, and medical research.

3 investors

Ashirase is a wearable navigation device that attaches to shoes and uses foot vibrations to guide visually impaired users to destinations without requiring visual attention or smartphone interaction. The device combines GNSS positioning, AI-powered features, and haptic feedback to support independent mobility for people with various vision levels.

3 investors

Gaudi Clinical is a Japanese company in the clinical and cellular field. Based on the company outline page, it appears to operate in cellular or clinical biotech, though the page does not explicitly detail specific products or services.

3 investors

Ai-BrainScience Inc. is a Japanese company holding a Type 2 medical device manufacturing and sales license. The company is registered as a medical device business, indicating a focus on medical technology and brain-related diagnostics.

3 investors

KURASERU develops software and digital transformation (DX) services for Japan's elderly-care industry, aiming to reduce the operational burden on care workers through technology. The company builds systems for care facilities, hospitals, and home-nursing providers.

2 investors

Reprocell is a biotechnology company that manufactures and sells iPS cell-related research reagents, provides drug discovery support services including iPS cell establishment and CRO services, and offers clinical testing and regenerative medicine product development.

2 investors

Init accompanies organizations through digital transformation processes, offering consulting, innovative technology solutions, and end-to-end digital implementations. The company serves public administration and enterprises seeking to make digitalization accessible and beneficial for society.

2 investors

Provides 24/7 telehealth services for skilled nursing and residential care facilities, offering virtual physician consultations and AI-based documentation and billing tools. Designed to support medical directors and staff by handling after-hours and overflow care and reducing hospital transfers.

2 investors

20/20 BioLabs develops AI-powered blood tests for early detection of multiple cancers and chronic diseases, using protein tumor markers and machine learning. The company offers affordable, at-home collection tests starting under $200, targeting individuals and healthcare providers seeking early disease detection.

2 investors

3Sunny provides SaaS-based web services for healthcare and long-term care facilities in Japan to address staffing shortages and rising operational costs in the medical and nursing care sectors.

2 investors

360Moms is a mobile app offering parenting and family care support, combining AI with a network of over 400 doctors and specialists to answer parents' questions and provide guidance. It also provides parenting tips content, healthy recipes, and family discounts, serving a community of over 100,000 families in Arabic-speaking markets.

2 investors

4D Healthware offers Virtual CCM, a technology platform for chronic care management that lets healthcare providers deliver care beyond the clinic in settings such as homes, pharmacies, grocery stores, workplaces, and online. It is aimed at healthcare providers seeking to extend patient care outside traditional clinical settings.

2 investors